Russell Investments Group, Ltd. Spero Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 6,400 shares of SPRO stock, worth $7,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,400

Previous 6,400 -0.0%

Holding current value

$7,552

Previous $8,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$0.74 - $7.44 $629 - $6,324	-850 Reduced 11.72%	6,400 $4,000
Q4 2021 Jan 21, 2022	SELL	$13.09 - $18.77 $11,741 - $16,836	-897 Reduced 11.01%	7,250 $116,000
Q3 2021 Nov 08, 2021	SELL	$13.03 - $19.51 $120,162 - $179,921	-9,222 Reduced 53.09%	8,147 $149,000
Q2 2021 Aug 04, 2021	SELL	$12.22 - $15.79 $388,571 - $502,090	-31,798 Reduced 64.67%	17,369 $241,000
Q1 2021 May 10, 2021	SELL	$13.23 - $21.48 $34,398 - $55,848	-2,600 Reduced 5.02%	49,167 $723,000
Q4 2020 Feb 08, 2021	SELL	$11.65 - $22.07 $754,465 - $1.43 Million	-64,761 Reduced 55.58%	51,767 $1.01 Million
Q3 2020 Nov 09, 2020	BUY	$8.96 - $14.12 $207,872 - $327,584	23,200 Added 24.86%	116,528 $1.29 Million
Q2 2020 Aug 05, 2020	BUY	$7.27 - $14.18 $600,407 - $1.17 Million	82,587 Added 768.89%	93,328 $1.26 Million
Q1 2020 May 06, 2020	BUY	$5.27 - $10.41 $25,680 - $50,727	4,873 Added 83.04%	10,741 $86,000
Q4 2019 Jan 29, 2020	BUY	$9.46 - $12.16 $55,511 - $71,354	5,868 New	5,868 $55,000
Q4 2018 Feb 11, 2019	SELL	$5.69 - $11.28 $7,397 - $14,664	-1,300 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$9.69 - $17.79 $6,783 - $12,453	-700 Reduced 35.0%	1,300 $14,000
Q2 2018 Aug 08, 2018	BUY	$10.41 - $17.85 $20,820 - $35,700	2,000 New	2,000 $29,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $41.4M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Spero Therapeutics, Inc. Transaction History